Catalyst
Slingshot members are tracking this event:
Radius Health (RDUS) Presented Pre-specified Subgroup Analyses from Phase 3 ACTIVE Trial Evaluating Abaloparatide-SC in Postmenopausal Women With Osteoporosis at ENDO 2016 Annual Meeting
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RDUS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 01, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Pre-specified Analyses, Phase 3 Active, Abaloparatide-sc, Postmenopausal Women, Osteoporosis, Endo 2016 Meeting
